4Muijseis HB,Plosker GL,Noble S.Sertraline:review of its use in themanagemt of major depressive disonier in elderly patients[J].DingsAging, 2002,19(5):377.
5Von Korff M, Ustun TB, Ormel J, et al. Self-report disability in an international primary care study of psychological illness. J Clin Epidemiol, 1996,49:297-303.
6Paul MA, Gray GW, Love R J, et al. SSRI effects on pyschomotor performance: assessment of citalopram and escitalopram on normal subjects. Aviat Space Environ Med, 2007, 78: 693~97.
7Siepmann M, Grossmann J, Miick-Weymann M, et al. Effects of sertraline on autonomic and cognitive functions in healthy volunteers. Psychopharmacology ( Berl), 2003,168:293-298.
8van Laar MW, Volkerts ER, Verbaten MN, et al. Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory. Psychopharmacology (Berl) ,2002,162:351-363.
9Pardo JV, Pardo PJ, Humes SW, et al. Neurocognitive dysfunction in antidepressant-free, notl-el.derly patients with unipolar depression: alerting and covert orienting of visuospatial attention. J Affect Disord, 2006, 92: 71-78.
10Riedel WJ, Eikmans K, Heldens A, et al. Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment. J Psychopharmacol,2005, 19:12-20.
